Drug Trial Radar · NCT00925054
Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU
Last checked: Nov 20, 2026Latest source record: Feb 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Sep 2009
Primary completion
Jun 2015
Study completion Jun 2015
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jun 19, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate whether weekly injections of phenylalanine ammonia lyase (rAvPAL-PEG) can reduce blood phenylalanine concentrations in PKU subjects and whether repeated administration is safe.
Conditions
- Phenylketonuria
Interventions
rAvPAL-PEG 0.001 mg/kgDrug
In Part 1, the planned starting dose levels is 0.001 mg/kg
rAvPAL-PEG 0.003 mg/kgDrug
In Part 1, the planned starting dose levels is 0.003 mg/kg
rAvPAL-PEG 0.01 mg/kgDrug
In Part 1, the planned starting dose levels is 0.01 mg/kg
rAvPAL-PEG 0.03 mg/kgDrug
In Part 1, the planned starting dose levels is 0.03 mg/kg
rAvPAL-PEG 0.1 mg/kgDrug
In Part 1, the planned starting dose levels is 0.1 mg/kg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood Phenylalanine ConcentrationsTime frame: Baseline, Week 1/Day 5, Week 7, Week 16/Day 106
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
The Children's Hospital
Aurora, Colorado
Emory Universty
Decatur, Georgia
Children's Memorial Hospital
Chicago, Illinois
University of Minnesota Medical Center-Fairview
Minneapolis, Minnesota
Washington University Center for Applied Research Sciences
St Louis, Missouri
Albany Medical Center
Albany, New York
Mount Sinai School of Medicine
New York, New York
Akron Children's Hospital
Akron, Ohio
Oregon Health & Science University
Portland, Oregon
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
University of Utah Hospital
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.